Advertisement

Topics

Latest "Hypercom Corporation" News Stories

18:31 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "Hypercom Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Hypercom Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Hypercom Corporation for you to read. Along with our medical data and news we also list Hypercom Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hypercom Corporation Companies for you to search.

Showing "Hypercom Corporation" News Articles 1–25 of 591

Thursday 13th December 2018

Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M

Press Release 13 December 2018 Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. Immunicum AB (publ) ("Immunicum"...


Ossur Hf : Financial calendar 2019

Announcement no. 71/201813 December 2018 Össur's financial calendar 2019 Interim Report Q4 2018 and Annual Report for 2018     5 February 2019 Annual General Meeting     7 March 2019 Interim Report Q1 2019    

Novartis receives European Commission approval for self-administration of Xolair® across all indications

Novartis International AG / Novartis receives European Commission approval for self-administration of Xolair® across all indications . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. The EC approval underscores the long-term safety and efficacy of Xolair demonstrated in clinical studies and by 13 years of re...


Pixium Vision awarded Galien Prize 2018 for research with PRIMA system

Pixium Vision awarded Galien Prize 2018 for research with PRIMA system for dry AMD Paris, France - December 13, 2018 - 7 AM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today that it has been awarded the Prix Galien 2018 in the &qu...

Wednesday 12th December 2018

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.Source: Ambu A/S via Globenewswire

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018

Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of healthy human skin in different body sites Findings support application of epicutaneous immunotherapy (EPIT) to int

Santhera Announces Financial Results for the First Nine Months of 2018

Santhera Pharmaceuticals Holding AG / Santhera Announces Financial Results for the First Nine Months of 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and...

Santhera Launches Placement of Shares through Accelerated Bookbuilding

Santhera Pharmaceuticals Holding AG / Santhera Launches Placement of Shares through Accelerated Bookbuilding . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5...

Acacia Pharma Group plc: Acacia Pharma announces positive clinical results for APD403 in chemotherapy induced nausea & vomiting published in Supportive Care in Cancer

ACACIA PHARMA ANNOUNCES POSITIVE CLINICAL RESULTS FOR APD403 IN CHEMOTHERAPY INDUCED NAUSEA & VOMITING PUBLISHED IN SUPPORTIVE CARE IN CANCER Cambridge, UK and Indianapolis, US - 12 December 2018: Acacia Pharma Group plc ("Acacia Pharma", the "Company") (EURONEXT: ACPH) announces that data and analyses from its positive Phase 2 clinical trial of APD403 (int...

Tuesday 11th December 2018

Santhera's Extraordinary General Meeting Approves Capital Increase

Santhera Pharmaceuticals Holding AG / Santhera's Extraordinary General Meeting Approves Capital Increase . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 11, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that a vast majority of shareholders approved the ordinary capit...

Neovacs and Centurion Pharma continue their collaboration in Lupus based on the results of the Phase IIb trial with IFNalpha Kinoid

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs and Centurion Pharma continue their collaboration in Lupusbased on the results of the Phase IIb trial with IFNalpha Kinoid Paris and Boston, December 11th 2018 - 7:30 am CET - Neovacs (Euronext Growth Paris: ALNEV), leader in the field of active immune therapy for the treatment of autoimmune-diseas

Monday 10th December 2018

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder

Novartis International AG / Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. reSET-OTM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics...

Santhera's Board of Directors Submits Amended Proposal to its Extraordinary General Meeting on December 11, 2018

Santhera Pharmaceuticals Holding AG / Santhera's Board of Directors Submits Amended Proposal to its Extraordinary General Meeting on December 11, 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 10, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that its Board o...

Inventiva invited to present at the 37th Annual J.P. Morgan Healthcare Conference

                                                Inventiva invited to present at the 37th Annual J.P. Morgan Healthcare Conference Daix (France), December 10, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH),...

Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine

DUBLIN - December 10, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America's Most JUST Companies in 2018, according to Forbes magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st on this year's JUST 100: America&...

Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled

Press release December 10, 2018 Appeal on Enzymatica's cold spray in Germany overruled Enzymatica has been informed that the Frankfurt Higher Regional Court - OLG (Oberlandesgericht) has overruled the appeal on a previous court ruling regarding the marketing of the mouth spray ViruProtect® in Germany. The OLG court claims that no new information has been brought forward t...

German Clinic Orders Second Acarix CADScor®System to Further Boost Patient Capacity

Press release Malmö, Sweden 10th of December 2018 German Clinic Orders Second Acarix CADScor®System to Further Boost Patient Capacity After three months of strong results using Acarix's CADScor®System to evaluate potential coronary artery disease, Dr Katarina Varga, who operates two clinics in Seifhennersdorf, Germany, has ordered her second system to evaluate even more patients wh...

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 5, 2018

Disclosure of Share Capital and Voting Rights Outstanding as of December 5, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (December 10, 2018) As of December 5, 2018, shares and voting rights outstanding of EssilorLuxottica, the global...

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2018

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (December 10, 2018) As of November 30, 2018, shares and voting rights outstanding of EssilorLuxottica, the globa...

Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea

Basilea Pharmaceutica AG / Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, Switzerland, December 10, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announc...

New member proposed for election to Roche Board of Directors

F. Hoffmann-La Roche Ltd / New member proposed for election to Roche Board of Directors . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, 10 December 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors (BoD) of Roche Holding Ltd decided on first pr...

Changes to the Roche Corporate Executive Committee

F. Hoffmann-La Roche Ltd / Changes to the Roche Corporate Executive Committee . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Basel, 10 December 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will be s...

Saturday 8th December 2018

Novartis data demonstrates consistent efficacy and tolerability of Kisqali® combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease

Novartis International AG / Novartis data demonstrates consistent efficacy and tolerability of Kisqali® combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement.  Subgroup analyses of three pivotal Phase II...

Friday 7th December 2018

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019

DUBLIN - December 7, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Ari...

Acacia Pharma Group plc: ACACIA PHARMA ANNOUNCES BARHEMSYS(TM) PDUFA DATE OF 5 MAY 2019

ACACIA PHARMA ANNOUNCES BARHEMSYS(TM) PDUFA DATE OF 5 MAY 2019 This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US - 7 December 2018: Acacia Pharma Group plc ("Acacia Pharma" or "the Company"), a pharmaceutical company developing and commercialising hospita...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks